首页 > 市场调查报告书 > 製药

再生医学细胞疗法

市场调查报告书

商品编码

1386503

先进治疗市场报告：2030 年趋势、预测与竞争分析

Advanced Therapy Medicinal Products Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年10月11日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

先进治疗药物的趋势与预测

到 2030 年，全球先进治疗药物市场预计将达到 199 亿美元，2024 年至 2030 年年复合成长率为 13.5%。该市场的主要驱动因素是医疗保健支出的增加、慢性病盛行率的增加、有利的法规环境和政府支持的扩大。全球先进治疗药物市场前景广阔，细胞治疗、CAR-T治疗、基因治疗、组织工程产品市场充满机会。

先进治疗市场洞察

Lucintel 预测，由于创伤治疗和再生医学应用的采用不断增加，组织工程产品仍将是最大的细分市场。

由于癌症、心血管疾病和神经退化性疾病等慢性病的高盛行率，北美仍然是最大的市场。

本报告回答了 11 个关键问题：

Q.1. 细分市场中最有前途和高成长的机会是什么？
Q.2. 哪个产业将以更快的速度成长？为什么？
Q.3.您认为哪些地区未来会出现更快的成长？为什么？
Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
Q.5. 这个市场的商业风险和竞争威胁是什么？
Q.6.这个市场有哪些新趋势？为什么？
Q.7.市场客户需求有何改变？
Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

成长机会分析
- 全球先进治疗药物市场成长机会（按产品）
- 按地区分類的全球先进治疗市场成长机会
全球先进治疗药物市场新趋势
战略分析
- 新产品开发
- 扩大全球先进治疗药物市场的产能
- 全球先进治疗收购和合资企业
- 认证和许可

第7章主要企业概况

Spark Therapeutics
Bluebird Bio
Novartis
UniQure
Celgene Corporation
Gilead Lifesciences
Kolon TissueGene
JCR Pharmaceuticals
MEDIPOST
Vericel Corporation

简介目录

Advanced Therapy Medicinal Products Trends and Forecast

The future of the global advanced therapy medicinal products market looks promising with opportunities in the cell therapy, CAR-T therapy, gene therapy, and tissue engineered product markets. The global advanced therapy medicinal products market is expected to reach an estimated $19.9 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are rising healthcare spending, increasing prevalence of chronic diseases, and favorable regulatory environment and growing government support.

A more than 150-page report is developed to help in your business decisions.

Advanced Therapy Medicinal Products by Segment

The study includes a forecast for the global advanced therapy medicinal products by product and region.

Advanced Therapy Medicinal Products Market by Product [Shipment Analysis by Value from 2018 to 2030]:

Cell Therapy
CAR-T Therapy
Gene Therapy
Tissue Engineered Product

Advanced Therapy Medicinal Products Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Advanced Therapy Medicinal Products Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies advanced therapy medicinal products companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the advanced therapy medicinal products companies profiled in this report include-

Spark Therapeutics
Bluebird Bio
Novartis
Uniqure
Celgene Corporation
Gilead Lifesciences
Kolon Tissuegene
JCR Pharmaceuticals
Medipost
Vericel Corporation

Advanced Therapy Medicinal Products Market Insights

Lucintel forecasts that tissue engineered product will remain the largest segment due to its increasing adoption in wound healing and regenerative medicine applications.

North America will remain the largest segment due to high prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurodegenerative diseases.

Features of the Global Advanced Therapy Medicinal Products Market

Market Size Estimates: Advanced therapy medicinal products market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Advanced therapy medicinal products size by product and region in terms of value ($B).

Regional Analysis: Advanced therapy medicinal products market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products and regions for the mucopolysaccharidosis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the advanced therapy medicinal products market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the advanced therapy medicinal products market size?

Answer: The global advanced therapy medicinal products market is expected to reach an estimated $19.9 billion by 2030.

Q.2 What is the growth forecast for advanced therapy medicinal products market?

Answer: The global advanced therapy medicinal products market is expected to grow with a CAGR of 13.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the advanced therapy medicinal products market?

Answer: The major drivers for this market are rising healthcare spending, increasing prevalence of chronic diseases and favorable regulatory environment and growing government support.

Q4. What are the major segments for advanced therapy medicinal products market?

Answer: The future of the advanced therapy medicinal products market looks promising with opportunities in the cell therapy, CAR-T therapy, gene therapy, and tissue engineered product markets.

Q5. Who are the key advanced therapy medicinal products market companies?

Answer: Some of the key advanced therapy medicinal products companies are as follows:

Spark Therapeutics
Bluebird Bio
Novartis
Uniqure
Celgene Corporation
Gilead Lifesciences
Kolon Tissuegene
JCR Pharmaceuticals
Medipost
Vericel Corporation

Q6. Which advanced therapy medicinal products market segment will be the largest in future?

Answer: Lucintel forecasts that tissue engineered product will remain the largest segment due to its increasing adoption in wound healing and regenerative medicine applications.

Q7. In advanced therapy medicinal products market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment due to high prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurodegenerative diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the advanced therapy medicinal products market by product (cell therapy, CAR-T therapy, gene therapy, and tissue engineered product), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Advanced Therapy Medicinal Products Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Advanced Therapy Medicinal Products Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Advanced Therapy Medicinal Products Market by Product
- 3.3.1: Cell Therapy
- 3.3.2: CAR-T Therapy
- 3.3.3: Gene Therapy
- 3.3.4: Tissue Engineered Product

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Advanced Therapy Medicinal Products Market by Region
4.2: North American Advanced Therapy Medicinal Products Market
4.3: European Advanced Therapy Medicinal Products Market
- 4.3.1: European Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product
4.4: APAC Advanced Therapy Medicinal Products Market
- 4.4.1: APAC Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product
4.5: ROW Advanced Therapy Medicinal Products Market
- 4.5.1: ROW Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Advanced Therapy Medicinal Products Market by Product
- 6.1.2: Growth Opportunities for the Global Advanced Therapy Medicinal Products Market by Region
6.2: Emerging Trends in the Global Advanced Therapy Medicinal Products Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Advanced Therapy Medicinal Products Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Advanced Therapy Medicinal Products Market
- 6.3.4: Certification and Licensing